Evaluation of circulating calcitonin: Analytical aspects

Antonia Martinetti, Ettore Seregni, Leonardo Ferrari, Federica Pallotti, Gianluca Aliberti, Angela Coliva, Silvia Fracassi, Emilio Bombardieri

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background and aim: Calcitonin (hCT) is a useful serum marker for the diagnosis and monitoring of medullary thyroid carcinoma (MTC). However, hCT values provided by different methods may differ, leading to difficulties In the interpretation of hCT results. In this study we compared four immunoradiometric (IRMA) and radiolmmunometric (RIA) assays for hCT determination. Material and methods: hCT was measured in 35 patients by means of the following commercially available IRMA or RIA kits: CT US (Biosource), IRMA hCT (Schering-CIS bio international), ultra-sensitive calcitonin (DSL), and calcitonin assay (Scantibodies). A comparison of the distribution of the hCT values measured by the tested IRMA-RIAs and a correlation analysis were performed. Results: The hCT values were widely dispersed and the classification of the patients according to the hCT cutoff value varled depending on the assay used. Conclusion: Despite efforts to develop new, highly specific antibodies, the evaluation of this marker is still flawed by analytical inaccuracy. hCT values are widely dispersed depending on the method used for marker measurement; as a consequence, patient classification according to the hCT cutoff value is still dependent on the assay used.

Original languageEnglish
Pages (from-to)566-568
Number of pages3
JournalTumori
Volume89
Issue number5
Publication statusPublished - Sep 2003

Fingerprint

Calcitonin
Biomarkers
Antibodies

Keywords

  • Calcitonin
  • Immunoradiometric assays
  • Medullary thyroid carcinomas

ASJC Scopus subject areas

  • Cancer Research

Cite this

Martinetti, A., Seregni, E., Ferrari, L., Pallotti, F., Aliberti, G., Coliva, A., ... Bombardieri, E. (2003). Evaluation of circulating calcitonin: Analytical aspects. Tumori, 89(5), 566-568.

Evaluation of circulating calcitonin : Analytical aspects. / Martinetti, Antonia; Seregni, Ettore; Ferrari, Leonardo; Pallotti, Federica; Aliberti, Gianluca; Coliva, Angela; Fracassi, Silvia; Bombardieri, Emilio.

In: Tumori, Vol. 89, No. 5, 09.2003, p. 566-568.

Research output: Contribution to journalArticle

Martinetti, A, Seregni, E, Ferrari, L, Pallotti, F, Aliberti, G, Coliva, A, Fracassi, S & Bombardieri, E 2003, 'Evaluation of circulating calcitonin: Analytical aspects', Tumori, vol. 89, no. 5, pp. 566-568.
Martinetti A, Seregni E, Ferrari L, Pallotti F, Aliberti G, Coliva A et al. Evaluation of circulating calcitonin: Analytical aspects. Tumori. 2003 Sep;89(5):566-568.
Martinetti, Antonia ; Seregni, Ettore ; Ferrari, Leonardo ; Pallotti, Federica ; Aliberti, Gianluca ; Coliva, Angela ; Fracassi, Silvia ; Bombardieri, Emilio. / Evaluation of circulating calcitonin : Analytical aspects. In: Tumori. 2003 ; Vol. 89, No. 5. pp. 566-568.
@article{d2636eab1e79402eb4feaa6602248dc5,
title = "Evaluation of circulating calcitonin: Analytical aspects",
abstract = "Background and aim: Calcitonin (hCT) is a useful serum marker for the diagnosis and monitoring of medullary thyroid carcinoma (MTC). However, hCT values provided by different methods may differ, leading to difficulties In the interpretation of hCT results. In this study we compared four immunoradiometric (IRMA) and radiolmmunometric (RIA) assays for hCT determination. Material and methods: hCT was measured in 35 patients by means of the following commercially available IRMA or RIA kits: CT US (Biosource), IRMA hCT (Schering-CIS bio international), ultra-sensitive calcitonin (DSL), and calcitonin assay (Scantibodies). A comparison of the distribution of the hCT values measured by the tested IRMA-RIAs and a correlation analysis were performed. Results: The hCT values were widely dispersed and the classification of the patients according to the hCT cutoff value varled depending on the assay used. Conclusion: Despite efforts to develop new, highly specific antibodies, the evaluation of this marker is still flawed by analytical inaccuracy. hCT values are widely dispersed depending on the method used for marker measurement; as a consequence, patient classification according to the hCT cutoff value is still dependent on the assay used.",
keywords = "Calcitonin, Immunoradiometric assays, Medullary thyroid carcinomas",
author = "Antonia Martinetti and Ettore Seregni and Leonardo Ferrari and Federica Pallotti and Gianluca Aliberti and Angela Coliva and Silvia Fracassi and Emilio Bombardieri",
year = "2003",
month = "9",
language = "English",
volume = "89",
pages = "566--568",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Evaluation of circulating calcitonin

T2 - Analytical aspects

AU - Martinetti, Antonia

AU - Seregni, Ettore

AU - Ferrari, Leonardo

AU - Pallotti, Federica

AU - Aliberti, Gianluca

AU - Coliva, Angela

AU - Fracassi, Silvia

AU - Bombardieri, Emilio

PY - 2003/9

Y1 - 2003/9

N2 - Background and aim: Calcitonin (hCT) is a useful serum marker for the diagnosis and monitoring of medullary thyroid carcinoma (MTC). However, hCT values provided by different methods may differ, leading to difficulties In the interpretation of hCT results. In this study we compared four immunoradiometric (IRMA) and radiolmmunometric (RIA) assays for hCT determination. Material and methods: hCT was measured in 35 patients by means of the following commercially available IRMA or RIA kits: CT US (Biosource), IRMA hCT (Schering-CIS bio international), ultra-sensitive calcitonin (DSL), and calcitonin assay (Scantibodies). A comparison of the distribution of the hCT values measured by the tested IRMA-RIAs and a correlation analysis were performed. Results: The hCT values were widely dispersed and the classification of the patients according to the hCT cutoff value varled depending on the assay used. Conclusion: Despite efforts to develop new, highly specific antibodies, the evaluation of this marker is still flawed by analytical inaccuracy. hCT values are widely dispersed depending on the method used for marker measurement; as a consequence, patient classification according to the hCT cutoff value is still dependent on the assay used.

AB - Background and aim: Calcitonin (hCT) is a useful serum marker for the diagnosis and monitoring of medullary thyroid carcinoma (MTC). However, hCT values provided by different methods may differ, leading to difficulties In the interpretation of hCT results. In this study we compared four immunoradiometric (IRMA) and radiolmmunometric (RIA) assays for hCT determination. Material and methods: hCT was measured in 35 patients by means of the following commercially available IRMA or RIA kits: CT US (Biosource), IRMA hCT (Schering-CIS bio international), ultra-sensitive calcitonin (DSL), and calcitonin assay (Scantibodies). A comparison of the distribution of the hCT values measured by the tested IRMA-RIAs and a correlation analysis were performed. Results: The hCT values were widely dispersed and the classification of the patients according to the hCT cutoff value varled depending on the assay used. Conclusion: Despite efforts to develop new, highly specific antibodies, the evaluation of this marker is still flawed by analytical inaccuracy. hCT values are widely dispersed depending on the method used for marker measurement; as a consequence, patient classification according to the hCT cutoff value is still dependent on the assay used.

KW - Calcitonin

KW - Immunoradiometric assays

KW - Medullary thyroid carcinomas

UR - http://www.scopus.com/inward/record.url?scp=0345735590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345735590&partnerID=8YFLogxK

M3 - Article

C2 - 14870789

AN - SCOPUS:0345735590

VL - 89

SP - 566

EP - 568

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 5

ER -